AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33794080 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado/Soy Unsaponifiables (ASU) for three months
Number of subjects: 40
Study 33794080 — intervention group
Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 40
Study 33794080 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado/Soy Unsaponifiables (ASU)
Number of subjects: 40
Study 33794080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35065931 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of carbon monoxide (CO) exposure
Number of subjects: 799
Study 35065931 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of PM2.5 exposure (≥ 129.9 and ≤ 2100 μg/m3)
Number of subjects: 799
Study 35065931 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to black carbon (BC)
Number of subjects: 799
Study 35227342 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience Training (RT), n = 54
Number of subjects: 107
Study 35227342 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control, n = 53
Number of subjects: 107
Study 35227342 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience Training (RT)
Number of subjects: 107
Study 33982949 — intervention group
Group type: EXPERIMENTAL
Intervention: Parechovirus infection
Number of subjects: 220
Study 33982949 — intervention group
Group type: EXPERIMENTAL
Intervention: Parechovirus and enterovirus co-infection
Number of subjects: 220
Study 33982949 — intervention group
Group type: COMPARATOR
Intervention: Anellovirus infection
Number of subjects: 220
Study 33915843 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training (2 times per week for 3 months)
Number of subjects: 50
Study 33915843 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Pilates training)
Number of subjects: 50
Study 33849205 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation
Number of subjects: 34
Study 33849205 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study 35258487 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Simulator (VRS)
Number of subjects: 77
Study 35258487 — intervention group
Group type: COMPARATOR
Intervention: Box-Trainer (BT)
Number of subjects: 77
Study 33211109 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term current low-dose aspirin use
Number of subjects: 4710504
Study 33211109 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic low-dose aspirin use
Number of subjects: 4710504
Study 33211109 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term current low-dose aspirin use (subcohort aged 40-59 years)
Number of subjects: 4710504
Study 33211109 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic low-dose aspirin use (subcohort aged 40-59 years)
Number of subjects: 4710504
Study 33211109 — intervention group
Group type: COMPARATOR
Intervention: No low-dose aspirin use (control group)
Number of subjects: 4710504
Study 34656303 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg) and elemental zinc (30 mg) daily for 6 months
Number of subjects: 1470
Study 34656303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1470
Study 33688713 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival reinstrumentation with enamel matrix derivative (EMD)
Number of subjects: 13
Study 33688713 — intervention group
Group type: COMPARATOR
Intervention: Subgingival reinstrumentation without enamel matrix derivative (EMD)
Number of subjects: 13
Study 33128496 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin care regimens containing β‐glucan
Number of subjects: 20
Study 33128496 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 20
Study 32448931 — intervention group
Group type: EXPERIMENTAL
Intervention: Disaster Worker Resiliency Training Program (DWRT) workshop (n=78)
Number of subjects: 167
Study 32448931 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (n=89)
Number of subjects: 167
Study 32467559 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release tacrolimus (0.2 mg/kg/day)
Number of subjects: 1198
Study 32467559 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.2 mg/kg/day)
Number of subjects: 1198
Study 32467559 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.3 mg/kg/day)
Number of subjects: 1198
Study 32467559 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.2 mg/kg/day) plus basiliximab
Number of subjects: 1198
Study 35675611 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day cervical preparation with osmotic dilators plus buccal misoprostol
Number of subjects: 0
Study 35675611 — intervention group
Group type: COMPARATOR
Intervention: Overnight osmotic dilators alone
Number of subjects: 0
Study 33763839 — intervention group
Group type: EXPERIMENTAL
Intervention: AChEI + CS
Number of subjects: 40
Study 33763839 — intervention group
Group type: EXPERIMENTAL
Intervention: CS
Number of subjects: 40
Study 33763839 — intervention group
Group type: COMPARATOR
Intervention: AChEI
Number of subjects: 40
Study 32734638 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgiflo® applied at the end of surgery over the whole operative field including the line of airway anastomosis
Number of subjects: 55
Study 32734638 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Surgiflo®)
Number of subjects: 55
Study 35349835 — intervention group
Group type: EXPERIMENTAL
Intervention: JianPiYiFei II granules
Number of subjects: 276
Study 35349835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study 33431358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) with combination cisplatin (50 mg/m2) plus doxorubicin (15 mg/m2)
Number of subjects: 16
Study 33431358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) with intense single-agent cisplatin (100 mg/m2)
Number of subjects: 16
Study 33431358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 16
Study 32291222 — intervention group
Group type: EXPERIMENTAL
Intervention: Group education, splinting, and nerve and tendon gliding exercises (n = 52)
Number of subjects: 105
Study 32291222 — intervention group
Group type: COMPARATOR
Intervention: Waitlist without additional care (n = 53)
Number of subjects: 105
Study 35473471 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week baby swimming intervention
Number of subjects: 27
Study 35473471 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study 35862782 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg intragastric administration)
Number of subjects: 58
Study 35862782 — intervention group
Group type: COMPARATOR
Intervention: Control (no simvastatin treatment)
Number of subjects: 58
Study 34423361 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3730
Study 34423361 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP and hs-cTnT
Number of subjects: 3730
Study 34423361 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcome risk score
Number of subjects: 3730
Study 34423361 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality risk model
Number of subjects: 3730
Study 33674231 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 69
Study 33674231 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical therapy (Med)
Number of subjects: 69
Study 34154906 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional continuous glucose monitoring (CGM)
Number of subjects: 100
Study 33031018 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR) - 70 mL (∼5 mmol nitrate)
Number of subjects: 8
Study 33031018 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) - 70 mL (∼0.003 mmol nitrate)
Number of subjects: 8
Study 35500015 — intervention group
Group type: EXPERIMENTAL
Intervention: READY (Acceptance and Commitment Therapy-based group resilience-training program)
Number of subjects: 240
Study 35500015 — intervention group
Group type: COMPARATOR
Intervention: Group relaxation program (control)
Number of subjects: 240
Study 33875528 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group utilizing photography
Number of subjects: 50
Study 33875528 — intervention group
Group type: COMPARATOR
Intervention: Control group (no photographs or feedback)
Number of subjects: 50
Study 34325134 — intervention group
Group type: EXPERIMENTAL
Intervention: High-efficiency particulate air filter air purifier
Number of subjects: 24
Study 34325134 — intervention group
Group type: COMPARATOR
Intervention: Placebo air purifier
Number of subjects: 24
Study 32277134 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session RFA (group 1)
Number of subjects: 56
Study 32277134 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-session RFA (group 2)
Number of subjects: 56
Study 35307538 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused therapy with medication management as needed
Number of subjects: 114
Study 35307538 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care psychoeducation with medication management as needed
Number of subjects: 114
Study 35307538 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Family-focused therapy and Enhanced care psychoeducation)
Number of subjects: 114
Study 32341190 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic scenario of severe functional disability (SD)
Number of subjects: 1588
Study 32341190 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic scenario of remaining in a vegetative state (VS)
Number of subjects: 1588
Study 34952870 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared care with mental health professionals in GP offices
Number of subjects: 0
Study 34952870 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without shared mental health professionals)
Number of subjects: 0
Study 32909467 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Exercise with Self-Regulatory BCTs
Number of subjects: 577
Study 32909467 — intervention group
Group type: COMPARATOR
Intervention: High Intensity Exercise without Self-Regulatory BCTs
Number of subjects: 577
Study 32909467 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-Moderate Intensity Exercise with Self-Regulatory BCTs
Number of subjects: 577
Study 32909467 — intervention group
Group type: COMPARATOR
Intervention: Low-to-Moderate Intensity Exercise without Self-Regulatory BCTs
Number of subjects: 577
Study 32909467 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Regulatory BCTs
Number of subjects: 577
Study 32909467 — intervention group
Group type: COMPARATOR
Intervention: No Self-Regulatory BCTs
Number of subjects: 577
Study 34129239 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapies (ATT)
Number of subjects: 329
Study 34129239 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy (Low-dose aspirin)
Number of subjects: 329
Study 34129239 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin monotherapy
Number of subjects: 329
Study 34129239 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT (Aspirin/Clopidogrel)
Number of subjects: 329
Study 34660630 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (supervised training program)
Number of subjects: 60
Study 34660630 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34132792 — intervention group
Group type: EXPERIMENTAL
Intervention: Student-centric algorithm
Number of subjects: 50000
Study 34132792 — intervention group
Group type: COMPARATOR
Intervention: Program-centric algorithm
Number of subjects: 50000
Study 32990607 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate and high-fiber diet and education
Number of subjects: 44
Study 32990607 — intervention group
Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 44
Study 35448942 — intervention group
Group type: EXPERIMENTAL
Intervention: IV HBB 20 mg in 1 ml (Hyoscine group)
Number of subjects: 160
Study 35448942 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (Control group)
Number of subjects: 160
Study 33169175 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stems
Number of subjects: 29
Study 33169175 — intervention group
Group type: COMPARATOR
Intervention: Standard-length stems
Number of subjects: 29
Study 35341991 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAM intervention (group-based behavioral intervention)
Number of subjects: 0
Study 35341991 — intervention group
Group type: COMPARATOR
Intervention: Usual T1D care
Number of subjects: 0
Study 33338505 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice (self-sampling at home for HPV testing)
Number of subjects: 335
Study 33338505 — intervention group
Group type: COMPARATOR
Intervention: Standard of care screening at the local health department (SCS)
Number of subjects: 335
Study 32685258 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid (10 mg/kg)
Number of subjects: 69
Study 32685258 — intervention group
Group type: COMPARATOR
Intervention: normal saline (placebo)
Number of subjects: 69
Study 36309673 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based postnatal care (midwife-led telephone counselling within 48 hours post-discharge plus telephone access to midwife during postnatal period)
Number of subjects: 400
Study 36309673 — intervention group
Group type: COMPARATOR
Intervention: Usual postnatal care
Number of subjects: 400
Study 36309673 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based postnatal care
Number of subjects: 400
Study 33827781 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting (CAS) or endarterectomy (CEA) in recent trials
Number of subjects: 5001
Study 33827781 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy in earlier trials
Number of subjects: 5001
Study 35565662 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus gasseri CP2305
Number of subjects: 80
Study 35565662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32219594 — intervention group
Group type: EXPERIMENTAL
Intervention: M1 anodal transcranial direct current stimulation (a-tDCS) with SRTT
Number of subjects: 39
Study 32219594 — intervention group
Group type: COMPARATOR
Intervention: Sham a-tDCS with SRTT
Number of subjects: 39
Study 32219594 — intervention group
Group type: COMPARATOR
Intervention: SRTT-only control
Number of subjects: 39
Study 33152119 — intervention group
Group type: EXPERIMENTAL
Intervention: STAT3 activation (evidence of activation determined by immunohistochemical analysis of STAT3 phosphorylation)
Number of subjects: 5694
Study 33152119 — intervention group
Group type: COMPARATOR
Intervention: No STAT3 activation
Number of subjects: 5694
Study 33301541 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Inclinometer (DI)
Number of subjects: 22
Study 33301541 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial Motion Capture (IMC)
Number of subjects: 22
Study 33301541 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape Measure (TM)
Number of subjects: 22
Study 35422208 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional Anesthesia (RA) with Dexmedetomidine (DEX: 1 μg/kg infused over 10 min followed by 0.5 μg/kg/h)
Number of subjects: 50
Study 35422208 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA) with Dexmedetomidine (DEX: 0.1 μg/kg/min over 10 min followed by 0.4‐0.7 μg/kg/h)
Number of subjects: 50
Study 33038782 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile extract nasal drop
Number of subjects: 74
Study 33038782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 35762612 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic retrorectus mesh reinforcement (mesh group)
Number of subjects: 120
Study 35762612 — intervention group
Group type: COMPARATOR
Intervention: Primary closure of midline laparotomy (no-mesh group)
Number of subjects: 120
Study 33638248 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Education Program (GEP)
Number of subjects: 253
Study 33638248 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp Education Program (WEP)
Number of subjects: 253
Study 33638248 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 253
Study 616782735 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise and resistance training for 3 months
Number of subjects: 100
Study 616782735 — intervention group
Group type: COMPARATOR
Intervention: Resistance training for 3 months (Control)
Number of subjects: 100
Study 32266395 — intervention group
Group type: EXPERIMENTAL
Intervention: Living alone
Number of subjects: 0
Study 32266395 — intervention group
Group type: COMPARATOR
Intervention: Informal caregivers
Number of subjects: 0
Study 32594135 — intervention group
Group type: EXPERIMENTAL
Intervention: prednisolone (10 mg daily) plus 5α-reductase inhibitor (finasteride 5 mg daily or dutasteride 0.5 mg daily)
Number of subjects: 19
Study 32594135 — intervention group
Group type: COMPARATOR
Intervention: prednisolone (10 mg daily)
Number of subjects: 19
Study 34320250 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg PTAH daily for 1.5 years (Group A)
Number of subjects: 142
Study 34320250 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg PTAH daily for 2 years (Group B)
Number of subjects: 142
Study 34320250 — intervention group
Group type: EXPERIMENTAL
Intervention: PTAH treatment
Number of subjects: 142
Study 33441203 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (school-based obesity intervention)
Number of subjects: 5926
Study 33441203 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 5926
Study 36167118 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) with a fixed stimulation current of 200 mA and pulse frequency of 20 Hz
Number of subjects: 8
Study 36167118 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) with higher currents (100-250 mA)
Number of subjects: 8
Study 36167118 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric muscle contractions
Number of subjects: 8
Study 36167118 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiarization session of electrical stimulation (ES)
Number of subjects: 8
Study 35947398 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 1944
Study 35947398 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 1944
Study 36120087 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 3350 17g once daily for 24 weeks
Number of subjects: 304
Study 36120087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study 33933090 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital thermography imaging
Number of subjects: 50
Study 33374465 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP of maximal conditioning contractions (PAP MCC)
Number of subjects: 7
Study 33374465 — intervention group
Group type: COMPARATOR
Intervention: PAP of maximal strength contractions (PAP MSC)
Number of subjects: 7
Study 35177180 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide combined with pulmonary surfactant (PS) at a dose of 0.25 mg/kg for intratracheal instillation with PS application.
Number of subjects: 122
Study 35177180 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with pulmonary surfactant (PS) alone at an initial dose of 200 mg/kg, followed by 100 mg/kg according to the condition.
Number of subjects: 122
Study 34258275 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated intervention based on protection motivation theory and implementation intention
Number of subjects: 125
Study 34258275 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 125
Study 36056473 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 14
Study 36056473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 33098992 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin (C)
Number of subjects: 135
Study 35322019 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight BMI group (28 kg/m2)
Number of subjects: 773
Study 35322019 — intervention group
Group type: EXPERIMENTAL
Intervention: Underweight BMI group
Number of subjects: 773
Study 35322019 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity group
Number of subjects: 773
Study 35322019 — intervention group
Group type: COMPARATOR
Intervention: Normal weight group
Number of subjects: 773
Study 32151211 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of intravenous zoledronate
Number of subjects: 1
Study 32151211 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplements
Number of subjects: 1
Study 35608106 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral infigratinib 125 mg daily on days 1-21 of a 28-day cycle for up to 52 weeks
Number of subjects: 218
Study 35608106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 33617696 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-access physiotherapy (PT)
Number of subjects: 78
Study 33617696 — intervention group
Group type: COMPARATOR
Intervention: Usual care by emergency physician
Number of subjects: 78
Study 37332625 — intervention group
Group type: EXPERIMENTAL
Intervention: Early literacy promotion (board books and reading promotion beginning with newborns)
Number of subjects: 120
Study 37332625 — intervention group
Group type: COMPARATOR
Intervention: Standard literacy promotion (beginning at 6 months, only weekly text messages on safety)
Number of subjects: 120
Study 36400394 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (intervention group)
Number of subjects: 236
Study 36400394 — intervention group
Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (control group)
Number of subjects: 236
Study 36400394 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (intervention group) for cervical spine patients
Number of subjects: 236